Literature DB >> 3598590

Changes in extracellular amino acids during soman- and kainic acid-induced seizures.

J V Wade, F E Samson, S R Nelson, T L Pazdernik.   

Abstract

Extracellular amino acid levels in the rat piriform cortex, an area highly susceptible to seizure-induced neuropathology, were determined by means of intracranial microdialysis. Seizures were induced by systemic administration of either soman (O-1,2,2-trimethylpropyl methylphosphonofluoridate), a potent inhibitor of acetylcholinesterase, or the excitotoxin kainic acid. Extracellular glutamate levels increased in animals with seizures shortly after administration of either convulsant, but this change was statistically significant only in the case of soman-treated animals. Extracellular taurine levels increased markedly, reaching two- and fourfold baseline levels during the second hour of soman- and kainic acid-induced seizures, respectively. Taurine levels did not increase in the subpopulation of soman-treated animals without seizures, a finding indicating that elevation of extracellular taurine level is seizure related. Thus, we propose that taurine efflux may be a physiological cellular response to neuronal changes produced by excitotoxic chemicals, either directly or as a consequence of seizures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598590     DOI: 10.1111/j.1471-4159.1987.tb02912.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

2.  Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats.

Authors:  M E Layton; T L Pazdernik
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

3.  Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Felicia Qashu; Maria F M Braga
Journal:  Neurotoxicology       Date:  2009-07-08       Impact factor: 4.294

4.  Alterations in brain glutathione homeostasis induced by the nerve gas soman.

Authors:  Lori K Klaidman; James D Adams; Robert Cross; Thomas L Pazdernik; Fred Samson
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

5.  In vivo glutamate decline associated with kainic acid-induced status epilepticus.

Authors:  Natalie M Zahr; Elena L Fasano Crawford; Oliver Hsu; Shara Vinco; Dirk Mayer; Torsten Rohlfing; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Brain Res       Date:  2009-08-26       Impact factor: 3.252

6.  Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Authors:  Snjezana Zaja-Milatovic; Ramesh C Gupta; Michael Aschner; Dejan Milatovic
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

Review 7.  The osmotic/calcium stress theory of brain damage: are free radicals involved?

Authors:  T L Pazdernik; M Layton; S R Nelson; F E Samson
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

8.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

Review 9.  Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy.

Authors:  Vassiliki Aroniadou-Anderjaska; Brita Fritsch; Felicia Qashu; Maria F M Braga
Journal:  Epilepsy Res       Date:  2008-01-15       Impact factor: 3.045

10.  Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists.

Authors:  M Berg; T Bruhn; F F Johansen; P Krogsgaard-Larsen; N H Diemer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.